María-Rocío Meini1, Leticia I Llarrull2, Alejandro J Vila3. 1. Área Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 570, 200 Rosario, Argentina. 2. Área Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 570, 200 Rosario, Argentina; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Predio CONICET Rosario, 2000 Rosario, Argentina. Electronic address: llarrull@ibr-conicet.gov.ar. 3. Área Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 570, 200 Rosario, Argentina; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Predio CONICET Rosario, 2000 Rosario, Argentina. Electronic address: vila@ibr-conicet.gov.ar.
Abstract
Metallo-β-lactamases are the latest resistance mechanism of pathogenic and opportunistic bacteria against carbapenems, considered as last resort drugs. The worldwide spread of genes coding for these enzymes, together with the lack of a clinically useful inhibitor, have raised a sign of alarm. Inhibitor design has been mostly impeded by the structural diversity of these enzymes. Here we provide a critical review of mechanistic studies of the three known subclasses of metallo-β-lactamases, analyzed at the light of structural and mutagenesis investigations. We propose that these enzymes present a modular structure in their active sites that can be dissected into two halves: one providing the attacking nucleophile, and the second one stabilizing a negatively charged reaction intermediate. These are common mechanistic elements in all metallo-β-lactamases. Nucleophile activation does not necessarily requires a Zn(II) ion, but a Zn(II) center is essential for stabilization of the anionic intermediate. Design of a common inhibitor could be therefore approached based in these convergent mechanistic features despite the structural differences.
Metallo-β-n class="Chemical">lactamases are the latest resistance mechanism of pathogenic and opportunistic bacteria against carbapenems, considered as last resort drugs. The worldwide spread of genes coding for these enzymes, together with the lack of a clinically useful inhibitor, have raised a sign of alarm. Inhibitor design has been mostly impeded by the structural diversity of these enzymes. Here we provide a critical review of mechanistic studies of the three known subclasses of metallo-β-lactamases, analyzed at the light of structural and mutagenesis investigations. We propose that these enzymes present a modular structure in their active sites that can be dissected into two halves: one providing the attacking nucleophile, and the second one stabilizing a negatively charged reaction intermediate. These are common mechanistic elements in all metallo-β-lactamases. Nucleophile activation does not necessarily requires a Zn(II) ion, but a Zn(II) center is essential for stabilization of the anionic intermediate. Design of a common inhibitor could be therefore approached based in these convergent mechanistic features despite the structural differences.
Authors: M Hernandez Valladares; A Felici; G Weber; H W Adolph; M Zeppezauer; G M Rossolini; G Amicosante; J M Frère; M Galleni Journal: Biochemistry Date: 1997-09-23 Impact factor: 3.162
Authors: James Spencer; Jonathan Read; Richard B Sessions; Steven Howell; G Michael Blackburn; Steven J Gamblin Journal: J Am Chem Soc Date: 2005-10-19 Impact factor: 15.419
Authors: Mahesh Aitha; Amy R Marts; Alex Bergstrom; Abraham Jon Møller; Lindsay Moritz; Lucien Turner; Jay C Nix; Robert A Bonomo; Richard C Page; David L Tierney; Michael W Crowder Journal: Biochemistry Date: 2014-11-13 Impact factor: 3.162
Authors: Laura Cendron; Antonio Quotadamo; Lorenzo Maso; Pierangelo Bellio; Martina Montanari; Giuseppe Celenza; Alberto Venturelli; Maria Paola Costi; Donatella Tondi Journal: ACS Med Chem Lett Date: 2019-03-27 Impact factor: 4.345
Authors: Allie Y Chen; Pei W Thomas; Zishuo Cheng; Nasa Y Xu; David L Tierney; Michael W Crowder; Walter Fast; Seth M Cohen Journal: ChemMedChem Date: 2019-05-24 Impact factor: 3.466
Authors: Jorgelina Morán-Barrio; María-Natalia Lisa; Nicole Larrieux; Salvador I Drusin; Alejandro M Viale; Diego M Moreno; Alejandro Buschiazzo; Alejandro J Vila Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191
Authors: Le Zhai; Yi-Lin Zhang; Joon S Kang; Peter Oelschlaeger; Lin Xiao; Sha-Sha Nie; Ke-Wu Yang Journal: ACS Med Chem Lett Date: 2016-02-16 Impact factor: 4.345